News
Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial
Carlos Grilo, PhD, professor of psychiatry and psychology; Ralitza Gueorguieva, PhD, senior research scientist in biostatistics, and Yale co-authors tested the effectiveness of cognitive-behavioral therapy, lisdexamfetamine, and the combination of the two for binge-eating disorder comorbid with obesity. The results were published in the American Journal of Psychiatry.
Source: The American Journal of Psychiatry